Síndrome de Fisher-Evans asociado a pancreatitis aguda
Medicina Crítica · 2021
DOI: 10.35366/100005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Crítica, 2021. Verfasst von Rafael Domínguez-Pérez. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Fisher-Evans syndrome or Evans syndrome is the manifestation of immune hemolytic anemia that may be simultaneous or subsequent to immune thrombocytopenia. Because its diagnosis is not common, there are currently no exact information about its prevalence. According to its origin, it can be an idiopathic or secondary event. We present the case of a 58-year-old male, who developed Fisher-Evans syndrome associated to acute pancreatitis, in the intensive care unit (ICU); characterized by immune hemolytic anemia (Coombs positive) and thrombocytopenia; also presented renal dysfunction. During his hospital stay, he received steroid treatment; intravenous methylprednisolone for three days, oral prednisone (1 mg/kg/day) and human immunoglobulin (0.4 g/kg/day) for five days.
Results
He presented clinical improvement, with resolution of anemia and thrombocytopenia. It was evaluated by the nephrology service; who established management with hemodialysis and performed renal biopsy with a report of interstitial tubular necrosis.
Conclusion
Early detection of this syndrome and timely management had a great impact on the clinical evolution of the patient. He was graduated from home and received follow-up by the nephrology and hematology services by external.
Zitieren
APA
Domínguez-Pérez, R. (2021). Síndrome de Fisher-Evans asociado a pancreatitis aguda. Medicina Crítica. https://doi.org/10.35366/100005
Vancouver
Domínguez-Pérez R. Síndrome de Fisher-Evans asociado a pancreatitis aguda. Medicina Crítica. 2021. doi:10.35366/100005
BibTeX
@article{DomnguezPrez2021,
author = {Domínguez-Pérez, Rafael},
title = {Síndrome de Fisher-Evans asociado a pancreatitis aguda},
journal = {Medicina Crítica},
year = {2021},
doi = {10.35366/100005}
}
EUVIMED